Ventyx Biosciences IncNASDAQ:VTYX
- LAST PRICE4.9300
- TODAY'S CHANGE (%)-0.2000 (-3.8986%)
- Bid / Lots4.7000/ 10
- Ask / Lots4.9000/ 56
- Open / Previous Close4.9000 / 5.1300
- Day Range
- 52 Week Range
- Volume559,669
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VTYX |
|---|---|---|
| 09:32 ET | 10312 | 4.89 |
| 09:34 ET | 6093 | 4.99 |
| 09:36 ET | 1865 | 4.93 |
| 09:38 ET | 1687 | 4.95 |
| 09:39 ET | 26549 | 4.87 |
| 09:41 ET | 1383 | 4.86 |
| 09:43 ET | 606 | 4.86 |
| 09:45 ET | 808 | 4.84 |
| 09:48 ET | 420 | 4.865 |
| 09:50 ET | 2345 | 4.82 |
| 09:52 ET | 2475 | 4.8155 |
| 09:54 ET | 2188 | 4.7917 |
| 09:56 ET | 7140 | 4.7606 |
| 09:57 ET | 2267 | 4.75 |
| 09:59 ET | 1470 | 4.73 |
| 10:01 ET | 2500 | 4.7794 |
| 10:03 ET | 509 | 4.7747 |
| 10:06 ET | 1451 | 4.8 |
| 10:08 ET | 3800 | 4.79 |
| 10:10 ET | 1350 | 4.79 |
| 10:12 ET | 1885 | 4.8197 |
| 10:14 ET | 2711 | 4.76 |
| 10:15 ET | 500 | 4.75 |
| 10:17 ET | 16198 | 4.8137 |
| 10:19 ET | 1900 | 4.83 |
| 10:21 ET | 400 | 4.82 |
| 10:24 ET | 4100 | 4.8482 |
| 10:26 ET | 1000 | 4.8383 |
| 10:28 ET | 6779 | 4.8 |
| 10:30 ET | 400 | 4.8 |
| 10:33 ET | 8329 | 4.735 |
| 10:35 ET | 1100 | 4.72 |
| 10:37 ET | 100 | 4.72 |
| 10:42 ET | 3734 | 4.74 |
| 10:44 ET | 4056 | 4.73 |
| 10:46 ET | 25644 | 4.7 |
| 10:48 ET | 3805 | 4.72 |
| 10:50 ET | 3600 | 4.75 |
| 10:51 ET | 200 | 4.74 |
| 10:53 ET | 508 | 4.73 |
| 10:55 ET | 7488 | 4.75 |
| 11:00 ET | 1063 | 4.75 |
| 11:02 ET | 499 | 4.77 |
| 11:04 ET | 10271 | 4.79 |
| 11:06 ET | 110 | 4.8083 |
| 11:09 ET | 560 | 4.77 |
| 11:11 ET | 730 | 4.74 |
| 11:15 ET | 801 | 4.75 |
| 11:18 ET | 1180 | 4.7584 |
| 11:20 ET | 2093 | 4.79 |
| 11:22 ET | 485 | 4.8 |
| 11:24 ET | 256 | 4.81 |
| 11:26 ET | 100 | 4.815 |
| 11:29 ET | 1100 | 4.8 |
| 11:31 ET | 1005 | 4.8 |
| 11:38 ET | 400 | 4.81 |
| 11:40 ET | 2169 | 4.82 |
| 11:42 ET | 9448 | 4.86 |
| 11:44 ET | 400 | 4.86 |
| 11:45 ET | 235 | 4.86 |
| 11:47 ET | 1856 | 4.86 |
| 11:49 ET | 100 | 4.86 |
| 11:51 ET | 8209 | 4.8 |
| 11:54 ET | 2100 | 4.81 |
| 11:56 ET | 100 | 4.79 |
| 11:58 ET | 100 | 4.8 |
| 12:00 ET | 1600 | 4.82 |
| 12:03 ET | 400 | 4.81 |
| 12:09 ET | 301 | 4.81 |
| 12:12 ET | 100 | 4.8 |
| 12:14 ET | 200 | 4.8 |
| 12:16 ET | 290 | 4.8 |
| 12:18 ET | 100 | 4.8 |
| 12:20 ET | 100 | 4.79 |
| 12:23 ET | 1920 | 4.78 |
| 12:25 ET | 9031 | 4.7899 |
| 12:27 ET | 100 | 4.775 |
| 12:30 ET | 1279 | 4.8 |
| 12:32 ET | 100 | 4.79 |
| 12:34 ET | 300 | 4.79 |
| 12:36 ET | 200 | 4.78 |
| 12:38 ET | 300 | 4.78 |
| 12:39 ET | 500 | 4.78 |
| 12:41 ET | 200 | 4.77 |
| 12:43 ET | 200 | 4.77 |
| 12:45 ET | 200 | 4.76 |
| 12:48 ET | 900 | 4.775 |
| 12:50 ET | 200 | 4.78 |
| 12:52 ET | 200 | 4.78 |
| 12:54 ET | 1745 | 4.805 |
| 12:56 ET | 200 | 4.805 |
| 12:59 ET | 400 | 4.8 |
| 01:01 ET | 3338 | 4.79 |
| 01:06 ET | 320 | 4.78 |
| 01:12 ET | 3032 | 4.79 |
| 01:14 ET | 200 | 4.8 |
| 01:17 ET | 5981 | 4.84 |
| 01:19 ET | 1071 | 4.84 |
| 01:21 ET | 976 | 4.855 |
| 01:24 ET | 2920 | 4.9 |
| 01:26 ET | 2100 | 4.87 |
| 01:28 ET | 200 | 4.87 |
| 01:30 ET | 200 | 4.89 |
| 01:32 ET | 3018 | 4.868 |
| 01:33 ET | 1412 | 4.87 |
| 01:35 ET | 700 | 4.852 |
| 01:39 ET | 200 | 4.85 |
| 01:42 ET | 235 | 4.86 |
| 01:44 ET | 3022 | 4.8416 |
| 01:48 ET | 400 | 4.85 |
| 01:50 ET | 1360 | 4.87 |
| 01:51 ET | 100 | 4.88 |
| 01:53 ET | 200 | 4.87 |
| 01:55 ET | 300 | 4.88 |
| 01:57 ET | 100 | 4.88 |
| 02:00 ET | 100 | 4.88 |
| 02:02 ET | 200 | 4.88 |
| 02:04 ET | 200 | 4.87 |
| 02:06 ET | 500 | 4.88 |
| 02:08 ET | 200 | 4.87 |
| 02:09 ET | 200 | 4.88 |
| 02:11 ET | 2271 | 4.83 |
| 02:13 ET | 100 | 4.82 |
| 02:15 ET | 502 | 4.83 |
| 02:18 ET | 175 | 4.83 |
| 02:20 ET | 100 | 4.83 |
| 02:22 ET | 1154 | 4.84 |
| 02:24 ET | 634 | 4.84 |
| 02:26 ET | 100 | 4.85 |
| 02:27 ET | 100 | 4.85 |
| 02:29 ET | 420 | 4.84 |
| 02:31 ET | 1718 | 4.83 |
| 02:33 ET | 950 | 4.81 |
| 02:36 ET | 1783 | 4.8 |
| 02:40 ET | 925 | 4.8 |
| 02:42 ET | 685 | 4.81 |
| 02:45 ET | 1900 | 4.79 |
| 02:47 ET | 100 | 4.79 |
| 02:49 ET | 100 | 4.78 |
| 02:56 ET | 100 | 4.78 |
| 02:58 ET | 1265 | 4.78 |
| 03:00 ET | 500 | 4.78 |
| 03:02 ET | 821 | 4.78 |
| 03:03 ET | 1387 | 4.8 |
| 03:05 ET | 1486 | 4.81 |
| 03:07 ET | 500 | 4.8 |
| 03:09 ET | 417 | 4.81 |
| 03:14 ET | 200 | 4.81 |
| 03:16 ET | 3242 | 4.83 |
| 03:18 ET | 603 | 4.8299 |
| 03:20 ET | 2494 | 4.81 |
| 03:21 ET | 1500 | 4.82 |
| 03:25 ET | 100 | 4.815 |
| 03:27 ET | 1590 | 4.82 |
| 03:32 ET | 5996 | 4.82 |
| 03:34 ET | 2099 | 4.835 |
| 03:36 ET | 1500 | 4.85 |
| 03:38 ET | 1438 | 4.88 |
| 03:39 ET | 1106 | 4.88 |
| 03:41 ET | 2886 | 4.88 |
| 03:43 ET | 1110 | 4.88 |
| 03:45 ET | 6147 | 4.84 |
| 03:48 ET | 300 | 4.845 |
| 03:50 ET | 5087 | 4.87 |
| 03:52 ET | 4510 | 4.86 |
| 03:54 ET | 4336 | 4.85 |
| 03:56 ET | 9716 | 4.88 |
| 03:57 ET | 11561 | 4.9 |
| 03:59 ET | 23344 | 4.93 |
Today
May 20, 2024
May 17, 2024
May 16, 2024
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences, from 4:05PM ET on Thursday May 16, 2024 by Dow Jones
4:05PM ET on Thursday May 16, 2024 by Dow JonesPress Release: Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer, from 8:00AM ET on Thursday May 16, 2024 by Dow Jones
8:00AM ET on Thursday May 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ventyx Biosciences Inc | 361.7M | -1.5x | --- |
Aura Biosciences Inc | 359.2M | -4.0x | --- |
Tourmaline Bio Inc | 351.4M | -2.5x | --- |
Skye Bioscience Inc | 345.2M | -2.7x | --- |
Anavex Life Sciences Corp | 344.5M | -7.8x | --- |
Shattuck Labs Inc | 348.5M | -3.8x | --- |
Company Information
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Contact Information
- Headquarters
- 12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
- Phone
- 858-945-2393
- Fax
- 302-655-5049
Executives
- Executive Chairperson of the Board
- Sheila Gujrathi
- President, Chief Executive Officer, Founder, Director
- Raju Mohan
- Chief Financial Officer
- Martin Auster
- Chief Operating Officer
- Matthew Moore
- Chief Scientific Officer
- John Nuss
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $361.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.24 |
Book Value | $4.12 |
P/E Ratio | -1.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
